Some oncologists are still battling to get their hands on genetic testing information to diagnose and treat cancer patients – and an upcoming pharma-supported workshop hopes to fix that.
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jennifer Burgesshttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJennifer Burgess2024-04-04 14:48:482024-04-04 14:59:48PCPA in the news – High demand topic for oncologists
PCPA invites medical oncologists and cancer nurses to immerse in the game-changing world of precision medicine
Melbourne. Due to high demand, Australia’s peak body for private cancer specialists will host a unique workshop for all medical oncologists and cancer nurses, to gain a practical immersion into how genomic testing can better refine diagnoses, help predict cancer behaviour and create more effective treatment plans for their patients.
Board member of the Private Cancer Physicians of Australia (PCPA) and workshop Master of Ceremonies, Dr Cameron McLaren, says genomic testing or precision medicine, is a powerful tool that remarkably unlocks the secrets of […]
Pharma News: The Senate Community Affairs References Committee, chaired by Green’s Senator Janet Rice, held a public hearing in Sydney yesterday, spearheading an Opposition-led inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers.
Addressing the committee, Associate Professor Christopher Steer, President of Private Cancer Physicians of Australia, emphasised “We need to end the cancer lottery where a patient with a particular diagnosis can get support for their treatment whereas another is denied … because […]
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jennifer Burgesshttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJennifer Burgess2024-02-06 14:32:122024-02-06 14:39:08PCPA in the news – Patient groups, clinicians and industry challenge the status quo at rare diseases inquiry hearing
PCPA in the news – High demand topic for oncologists
/in News, PCPA in the news /by Jennifer BurgessPosted 15 February 2024
Some oncologists are still battling to get their hands on genetic testing information to diagnose and treat cancer patients – and an upcoming pharma-supported workshop hopes to fix that.
Click here to read full article.
PCPA in the news – PCPA Launches Practical Genomics Workshop
/in News, PCPA in the news, Uncategorized /by Jennifer Burgess15 February 2024
PCPA invites medical oncologists and cancer nurses to immerse in the game-changing world of precision medicine
Melbourne. Due to high demand, Australia’s peak body for private cancer specialists will host a unique workshop for all medical oncologists and cancer nurses, to gain a practical immersion into how genomic testing can better refine diagnoses, help predict cancer behaviour and create more effective treatment plans for their patients.
Board member of the Private Cancer Physicians of Australia (PCPA) and workshop Master of Ceremonies, Dr Cameron McLaren, says genomic testing or precision medicine, is a powerful tool that remarkably unlocks the secrets of […]
PCPA in the news – Patient groups, clinicians and industry challenge the status quo at rare diseases inquiry hearing
/in News, PCPA in the news /by Jennifer BurgessHealth Industry Hub 1 February 2024
Pharma News: The Senate Community Affairs References Committee, chaired by Green’s Senator Janet Rice, held a public hearing in Sydney yesterday, spearheading an Opposition-led inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers.
Addressing the committee, Associate Professor Christopher Steer, President of Private Cancer Physicians of Australia, emphasised “We need to end the cancer lottery where a patient with a particular diagnosis can get support for their treatment whereas another is denied … because […]